BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36931168)

  • 1. Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy-A meta-analysis.
    Pope V; Sivashanmugathas V; Moodley D; Gunaratnam L; Barra L
    Semin Arthritis Rheum; 2023 Jun; 60():152189. PubMed ID: 36931168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
    J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.
    Sacri AS; Chambaraud T; Ranchin B; Florkin B; Sée H; Decramer S; Flodrops H; Ulinski T; Allain-Launay E; Boyer O; Dunand O; Fischbach M; Hachulla E; Pietrement C; Le Pogamp P; Stephan JL; Belot A; Nivet H; Nobili F; Guillevin L; Quartier P; Deschênes G; Salomon R; Essig M; Harambat J
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i104-12. PubMed ID: 25676121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement.
    Chu X; Hong Y; Wang Y; Yu C; Wang L; Tong H; Yan J; Zhang Z; Xu G; Yao Y; Zeng R
    Am J Nephrol; 2021; 52(12):899-908. PubMed ID: 34875652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
    Wacrenier S; Riou J; Jourdain P; Guibert F; Henry N; Djema A; Coindre JP; Crochette R; Cousin M; Croue A; Subra JF; Piccoli G; Augusto JF; Brilland B
    Nephrol Dial Transplant; 2022 May; 37(6):1078-1087. PubMed ID: 33856482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Renal Transplantation in ANCA-Associated Vasculitis.
    Long X; Yang X; Yao S; Wu J
    Ann Transplant; 2024 Mar; 29():e943433. PubMed ID: 38528671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of ANCA-associated renal vasculitis patients with chronic dialysis.
    Chen YX; Zhang W; Chen XN; Ni LY; Shen PY; Wang WM; Chen N
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S5-10. PubMed ID: 24480250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454396
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.
    McAdoo SP; Tanna A; Hrušková Z; Holm L; Weiner M; Arulkumaran N; Kang A; Satrapová V; Levy J; Ohlsson S; Tesar V; Segelmark M; Pusey CD
    Kidney Int; 2017 Sep; 92(3):693-702. PubMed ID: 28506760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Center 10-Year Experience.
    Silva RM; Leal R; Marques MG; Rodrigues L; Santos L; Romãozinho C; Alves R; Figueiredo A
    Transplant Proc; 2023; 55(6):1396-1399. PubMed ID: 37202303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody subtypes and titers predict clinical outcomes in ANCA-associated vasculitis.
    Aljuhani M; Makati D; Hoff A; Thompson J; Pellegrino B; Shawwa K; Schmidt R; Kannabhiran D
    Rheumatol Int; 2021 May; 41(5):965-972. PubMed ID: 33585954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Matrix Metalloproteinase 7 Activated by Oxidative Stress Predicts Kidney Prognosis in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wu L; Wang G; Yang B; Liu X; Xie C; Feng X; Jin L; Zhou Z; Yang M; Zhou Z; Su C; Li Y; Song Y; Cao W
    Antioxid Redox Signal; 2022 Aug; 37(4-6):246-256. PubMed ID: 35152729
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of a renal risk score in a cohort of children with ANCA-associated glomerulonephritis.
    Zhang P; Yao J; Gao CL; Fang X; Zhang ZQ; Xia ZK
    J Investig Med; 2023 Dec; 71(8):854-864. PubMed ID: 37615067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis.
    Kouri AM; Andreoli SP
    Pediatr Nephrol; 2017 Mar; 32(3):449-455. PubMed ID: 27677979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the risk factors for end‑stage renal disease and mortality in ANCA-associated vasculitis: a study from a single center of the Chinese Rheumatism Data Center.
    Guo Q; Yu L; Zhang X; Shang J; Duan X
    Clin Rheumatol; 2023 Feb; 42(2):489-499. PubMed ID: 36367596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy.
    Merino JL; Galeano C; Espejo B; Rivera M; Fernández-Lucas M; Caldés S; Plana MN; Letosa M; Teruel JL; Quereda C; Ortuño J
    Nephrol Dial Transplant; 2011 Apr; 26(4):1360-6. PubMed ID: 20810451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study.
    Nelveg-Kristensen KE; Szpirt W; Carlson N; McClure M; Jayne D; Dieperink H; Gregersen JW; Krarup E; Ivarsen P; Torp-Pedersen C; Egfjord M
    Nephrol Dial Transplant; 2021 Dec; 37(1):63-71. PubMed ID: 33313875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of kidney transplantation in pediatric patients with ANCA-associated glomerulonephritis: a single-center experience.
    Noone D; Yeung RSM; Hebert D
    Pediatr Nephrol; 2017 Dec; 32(12):2343-2350. PubMed ID: 28766066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.